BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $5,944,000 | -89.9% | 40,800 | -91.8% | 0.08% | -88.4% |
Q1 2022 | $58,914,000 | -20.0% | 496,900 | -7.1% | 0.71% | -14.2% |
Q4 2021 | $73,677,000 | +169.9% | 534,600 | +172.1% | 0.83% | +163.9% |
Q3 2021 | $27,296,000 | +49.1% | 196,500 | +4.2% | 0.31% | +31.0% |
Q2 2021 | $18,303,000 | +2025.8% | 188,500 | +1396.0% | 0.24% | +1157.9% |
Q1 2021 | $861,000 | -98.4% | 12,600 | -98.0% | 0.02% | -98.5% |
Q4 2020 | $54,693,000 | +249.8% | 638,106 | +165.3% | 1.25% | +240.7% |
Q3 2020 | $15,635,000 | -68.1% | 240,500 | -64.1% | 0.37% | -77.6% |
Q2 2020 | $48,969,000 | +513.8% | 669,816 | +185.8% | 1.63% | +261.6% |
Q1 2020 | $7,978,000 | -83.8% | 234,352 | -74.2% | 0.45% | -72.8% |
Q4 2019 | $49,370,000 | +32.0% | 906,900 | +1.1% | 1.66% | -14.7% |
Q3 2019 | $37,406,000 | +73.9% | 896,600 | +82.6% | 1.95% | +79.7% |
Q2 2019 | $21,507,000 | +87.0% | 491,100 | +119.8% | 1.08% | +70.8% |
Q1 2019 | $11,498,000 | – | 223,400 | – | 0.63% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |